SPCC320.05 Antibody

What is SPCC320.05 and why is it significant in fission yeast research?

SPCC320.05 is a gene identifier in Schizosaccharomyces pombe (fission yeast) that encodes the Sup11p protein. This protein has been identified as essential for β-1,6-glucan synthesis and septum formation during cell division. The significance of this protein lies in its critical role in maintaining cell wall integrity and proper cell division processes in fission yeast. Studying SPCC320.05/Sup11p provides valuable insights into fundamental cellular processes of cell wall biosynthesis and cytokinesis, which can inform broader understanding of these mechanisms across eukaryotes.

How is SPCC320.05 related to Sup11p, and what cellular functions does it regulate?

SPCC320.05 is the systematic identifier for the gene encoding Sup11p in S. pombe. Functionally, Sup11p plays two major roles: it is essential for β-1,6-glucan synthesis in the cell wall and for proper septum formation during cell division. Research indicates that Sup11p depletion completely abolishes β-1,6-glucan in the cell wall, leading to significant structural defects. Additionally, conditional sup11 mutants exhibit malformed septa with aberrant β-1,3-glucan accumulation. Sup11p also functions as a multicopy suppressor of O-mannosylation mutants (nmt81-oma2), highlighting its involvement in glycosylation pathways that are crucial for proper protein function and cellular integrity.

What experimental approaches are available for studying SPCC320.05/Sup11p?

The study of SPCC320.05/Sup11p can be approached through multiple experimental techniques:

• Genetic manipulation: Creation of conditional mutants or gene knockouts to assess phenotypic changes

• Protein detection methods: Using antibodies for Western blotting, immunoprecipitation, and immunofluorescence

• Proteomic analysis: Mass spectrometry-based approaches to identify protein interactions

• Microscopy: Fluorescence microscopy with tagged proteins to visualize localization and dynamics

For antibody-based detection specifically, researchers typically employ polyclonal or monoclonal antibodies targeting Sup11p for Western blotting, immunoprecipitation (IP), and immunofluorescence (IF) applications. These approaches have contributed significantly to our understanding of Sup11p's role in cell wall biosynthesis and cytokinesis.

Does a specific commercial antibody exist for SPCC320.05/Sup11p?

Currently, no commercial antibody explicitly named "SPCC320.05 Antibody" exists in public databases. Researchers studying this protein typically develop custom antibodies against Sup11p or use epitope tagging approaches (e.g., GFP, FLAG) to facilitate detection. When developing custom antibodies, researchers should consider:

• Generating polyclonal antibodies against purified Sup11p or synthetic peptides derived from unique regions of the protein

• Developing monoclonal antibodies for increased specificity if repeated experiments are planned

• Using genetic approaches to tag the endogenous protein with GFP, HA, or FLAG epitopes, then using commercial antibodies against these tags

The lack of commercial antibodies reflects the specialized nature of this research, which is typical for many yeast proteins that aren't conserved in mammals or aren't disease-related .

How can I validate an antibody against SPCC320.05/Sup11p?

Validation of antibodies against SPCC320.05/Sup11p should follow these methodological approaches:

• Specificity testing: Use knockout (KO) cell lines as negative controls to confirm target selectivity. The antibody should show no signal in cells where Sup11p has been deleted or depleted.

• Cross-reactivity assessment: Perform adsorption against human/mouse IgG to reduce non-specific binding, particularly important when working with yeast proteins.

• Multiple application validation: Test the antibody in different applications (Western blot, IP, IF) with appropriate controls to ensure functionality across desired experimental conditions.

• Reproducibility evaluation: Document performance metrics across multiple experiments, potentially using standardized reporting systems like ZENODO for reproducibility.

Remember that validation requirements may differ depending on the specific application, as antibody performance can vary significantly between techniques like Western blotting and immunofluorescence.

What are the best strategies for developing custom antibodies against SPCC320.05/Sup11p?

When developing custom antibodies against SPCC320.05/Sup11p, consider these research-backed strategies:

• Epitope selection: Analyze the protein sequence to identify unique, exposed regions that are likely to be immunogenic. Avoid regions with high homology to other proteins to minimize cross-reactivity.

• Immunization approaches:

  • For polyclonal antibodies: Immunize rabbits or other suitable host animals with purified protein or conjugated peptides

  • For monoclonal antibodies: Use mouse or rat models followed by hybridoma screening

• Purification methods:

  • Affinity purification against the immunogen

  • Negative selection against related proteins to improve specificity

• Validation strategy: Implement a hierarchical validation approach that includes:

This approach addresses the challenge that approximately 15% of proteins lack renewable antibodies, a gap that affects many yeast proteins including potential homologs of Sup11p.

What are the optimal protocols for Western blotting using antibodies against SPCC320.05/Sup11p?

For optimal Western blotting detection of SPCC320.05/Sup11p, researchers should consider the following protocol adaptations:

• Sample preparation:

  • Lyse cells using glass bead disruption in a buffer containing protease inhibitors

  • Prepare membrane-enriched fractions given Sup11p's role in cell wall synthesis

  • Use detergents appropriate for membrane proteins (e.g., 1% Triton X-100)

• Gel electrophoresis and transfer:

  • Resolve lysates via SDS-PAGE (10-12% gels generally work well)

  • Use wet transfer for optimal results with membrane proteins

• Blocking and antibody incubation:

  • Block with 5% non-fat dry milk or BSA in TBST

  • Incubate with anti-Sup11p primary antibody at optimized dilutions (typically 1:1000-1:5000)

  • Visualize using HRP-conjugated secondary antibodies and enhanced chemiluminescence detection

• Controls:

  • Include wild-type and sup11 mutant samples

  • Consider including samples from cells with epitope-tagged Sup11p

  • Use anti-tubulin or similar as loading control

Based on related studies, this approach allows for reliable detection of Sup11p and assessment of its expression levels under various experimental conditions .

How can I optimize immunofluorescence techniques for visualizing SPCC320.05/Sup11p localization?

Optimizing immunofluorescence for SPCC320.05/Sup11p visualization requires attention to several methodological details:

• Cell fixation and permeabilization:

  • Fix cells with 3-4% formaldehyde for 30-60 minutes

  • Permeabilize the cell wall with zymolyase treatment (optimal concentration should be determined empirically)

  • Follow with brief treatment with 0.1% Triton X-100 to improve antibody access

• Antibody incubation and detection:

  • Block with 1-5% BSA in PBS

  • Incubate with anti-Sup11p primary antibody at optimized dilution

  • Visualize using fluorophore-labeled secondary antibodies (e.g., DyLight594)

• Co-staining recommendations:

  • DAPI for nuclear visualization

  • Calcofluor White for cell wall/septum visualization

  • Anti-Sec61 or similar for ER co-localization studies

• Microscopy specifications:

  • Use confocal microscopy for optimal resolution

  • Consider structured illumination microscopy for higher resolution localization studies

Note that large-scale antibody screens have shown that only about 46% (30/65) of targets had successful IF antibodies, highlighting the importance of careful optimization for this application.

What is the best approach for immunoprecipitation of SPCC320.05/Sup11p protein complexes?

For successful immunoprecipitation of SPCC320.05/Sup11p protein complexes, consider this methodological approach:

• Lysate preparation:

  • Use gentle lysis conditions to preserve protein-protein interactions

  • Include appropriate detergents (0.5-1% NP-40 or Triton X-100)

  • Maintain stringent protease inhibitor cocktails throughout

• Immunoprecipitation procedure:

  • Pre-clear lysates with Protein A/G beads

  • Incubate with anti-Sup11p antibody at 4°C for 2-4 hours or overnight

  • Capture complexes using Protein A/G beads

  • Wash extensively with decreasing detergent concentrations

• Complex analysis:

  • Validate precipitated complexes by SDS-PAGE and immunoblotting

  • Consider mass spectrometry analysis for comprehensive interactome characterization

• Control experiments:

  • Include IgG-only controls

  • Use lysates from sup11 mutants as negative controls

This approach allows for identification of Sup11p-interacting proteins that may provide insight into its functional networks in β-1,6-glucan synthesis and septum formation pathways .

Why might my Western blot for SPCC320.05/Sup11p show multiple bands or high background?

Multiple bands or high background in SPCC320.05/Sup11p Western blots could result from several factors:

• Antibody specificity issues:

  • The antibody may recognize related proteins or degradation products

  • Solution: Validate antibody with knockout controls and optimize antibody concentration

• Protein modification states:

  • Sup11p may undergo post-translational modifications resulting in multiple bands

  • Solution: Treat samples with phosphatases or glycosidases to determine if modifications cause band shifts

• Sample preparation problems:

  • Incomplete denaturation or protein degradation during extraction

  • Solution: Optimize lysis buffer composition, add additional protease inhibitors, and ensure complete sample denaturation

• Technical issues:

  • Insufficient blocking or washing

  • Solution: Increase blocking time/concentration and implement more stringent washing steps

If cross-reactivity remains problematic, adsorption against human/mouse IgG has been shown to reduce non-specific binding in yeast protein detection.

How can I differentiate between specific and non-specific signals in immunofluorescence experiments?

Differentiating between specific and non-specific signals in immunofluorescence requires systematic controls and analysis:

• Essential controls:

  • Knockout/knockdown samples: Should show absence of specific signal

  • Secondary antibody-only: Reveals background from secondary antibody

  • Pre-immune serum (for polyclonal antibodies): Indicates background from host antibodies

• Signal validation approaches:

  • Co-localization with known markers of expected subcellular locations

  • Correlation of signal changes with genetic manipulations (e.g., overexpression should increase signal)

  • Peptide competition: Pre-incubating antibody with immunizing peptide should abolish specific signals

• Technical considerations:

  • Optimize fixation and permeabilization for cell wall proteins

  • Adjust antibody concentration to maximize signal-to-noise ratio

  • Consider using super-resolution microscopy for more precise localization

Remember that in large-scale antibody screens, less than half of antibodies work successfully for immunofluorescence applications, suggesting this technique requires particularly careful optimization and validation.

What strategies can help resolve inconsistent results between different experimental approaches?

When facing inconsistent results between experimental approaches studying SPCC320.05/Sup11p, consider these resolution strategies:

• Systematic method comparison:

  • Document specific conditions for each technique

  • Create a table comparing variables across experiments (antibody lots, buffer compositions, cell growth conditions)

  • Test whether differences might reflect biological reality rather than technical artifacts

• Biological versus technical variability assessment:

  Variability Source	Identification Method	Resolution Approach
  Biological (strain differences)	Results cluster by strain regardless of technique	Standardize strains across experiments
  Technical (antibody performance)	Results cluster by technique regardless of strain	Validate antibodies using knockout controls
  Environmental (growth conditions)	Results vary with slight changes in media/temperature	Strictly standardize growth protocols

• Integrated approach:

  • Use orthogonal techniques to verify key findings

  • Combine genetic approaches (tagged proteins) with antibody-based detection

  • Validate with functional assays (e.g., measuring β-1,6-glucan levels)

• Literature reconciliation:

  • Review how similar discrepancies were resolved in studies of related proteins

  • Consider whether differences reflect distinct protein states or populations

These strategies address the challenge that protein detection methods can yield different results based on protein conformation, accessibility, and experimental conditions .

How can I design experiments to study the interaction between SPCC320.05/Sup11p and the cell wall synthesis machinery?

To investigate interactions between SPCC320.05/Sup11p and cell wall synthesis machinery, consider these advanced experimental approaches:

• Proximity-based interaction studies:

  • BioID or TurboID fusion proteins to identify proximal proteins in living cells

  • Split-GFP complementation to validate direct interactions

  • FRET/FLIM microscopy to measure interaction dynamics in real-time

• Genetic interaction mapping:

  • Synthetic genetic array (SGA) analysis with sup11 conditional mutants

  • Suppressor screens to identify genes that rescue sup11 mutant phenotypes

  • Epistasis analysis with other cell wall synthesis genes

• Biochemical complex characterization:

  • Blue native PAGE to preserve and analyze native protein complexes

  • Sucrose gradient fractionation to separate complexes by size

  • Cross-linking mass spectrometry (XL-MS) to map interaction interfaces

• Functional assays:

  • Quantitative analysis of β-1,6-glucan and β-1,3-glucan in various genetic backgrounds

  • In vitro reconstitution of enzyme activities with purified components

  • Time-resolved analysis of septum formation using live-cell imaging

These approaches build upon the established role of Sup11p in β-1,6-glucan synthesis and its function as a multicopy suppressor of O-mannosylation mutants, suggesting involvement in multiple aspects of cell wall biogenesis.

What are the most sensitive methods for detecting changes in SPCC320.05/Sup11p expression levels?

For detecting subtle changes in SPCC320.05/Sup11p expression levels, consider these advanced quantitative methods:

• Quantitative proteomics approaches:

  • SILAC (Stable Isotope Labeling with Amino acids in Cell culture) for direct comparison

  • TMT (Tandem Mass Tag) labeling for multiplexed comparison across conditions

  • PRM (Parallel Reaction Monitoring) for targeted, highly sensitive detection

• Advanced immunoblotting techniques:

  • Capillary Western systems (e.g., Wes, Jess) for higher sensitivity and reproducibility

  • Fluorescent Western blotting with internal standards for precise quantification

  • Multiplex Western blotting to simultaneously normalize to multiple loading controls

• Microscopy-based quantification:

  • Quantitative image analysis of immunofluorescence with standardized acquisition parameters

  • FACS analysis of GFP-tagged Sup11p to measure expression at single-cell resolution

• Transcriptional analysis:

  • RT-qPCR for mRNA quantification

  • RNA-seq for genome-wide expression context

  • Single-molecule FISH to assess transcriptional heterogeneity

When applying these methods, it's crucial to include appropriate controls and statistical analysis to detect significant changes. For instance, in proteomic studies, standardized scatter plot analysis (as shown in reference ) can effectively compare protein abundance between samples, with specific thresholds (e.g., 4-fold change) determining significance .

How can SPCC320.05/Sup11p research inform our understanding of cell wall synthesis inhibitors and antifungal development?

SPCC320.05/Sup11p research has significant implications for antifungal development through these advanced research directions:

• Target validation approaches:

  • Conditional degradation systems (e.g., auxin-inducible degrons) to titrate Sup11p levels

  • Chemical-genetic profiling to identify compounds that specifically synergize with sup11 mutations

  • Comparative analysis of Sup11p homologs across fungal species to identify conserved targetable domains

• Structural biology integration:

  • Determine the 3D structure of Sup11p using X-ray crystallography or cryo-EM

  • Conduct in silico screening for binding pockets suitable for small molecule inhibitors

  • Perform structure-based drug design targeting critical functional domains

• Translational research directions:

  • Investigate whether Sup11p homologs in pathogenic fungi have similar essential functions

  • Develop assays to screen for compounds that specifically inhibit β-1,6-glucan synthesis

  • Assess whether inhibition of Sup11p function leads to increased susceptibility to existing antifungals

• Resistance mechanism studies:

  • Characterize potential mechanisms of resistance to Sup11p inhibition

  • Identify compensatory pathways that might be activated upon Sup11p disruption

  • Design combination approaches to prevent resistance development

This research is particularly relevant because fungal cell wall components like β-1,6-glucan are absent in mammalian cells, making them excellent targets for selective antifungal agents. The essential nature of Sup11p for β-1,6-glucan synthesis suggests that inhibitors targeting this protein could have potent antifungal activity.

What approaches can be used to study post-translational modifications of SPCC320.05/Sup11p?

To investigate post-translational modifications (PTMs) of SPCC320.05/Sup11p, consider these advanced methodological approaches:

• Mass spectrometry-based PTM mapping:

  • Enrichment strategies for specific modifications (e.g., TiO₂ for phosphopeptides)

  • ETD/EThcD fragmentation for improved PTM site localization

  • Quantitative approaches to measure dynamic changes in modification status

• Site-specific mutation analysis:

  • Create point mutations at predicted modification sites

  • Assess functional consequences through phenotypic analysis

  • Combine with structural studies to understand mechanistic impacts

• PTM-specific detection methods:

  • Develop or apply modification-specific antibodies (e.g., phospho-specific)

  • Use mobility shift assays to detect modifications that alter protein migration

  • Apply ProQ Diamond/SYPRO Ruby staining for phosphorylation/total protein visualization

• PTM dynamics investigation:

  PTM Type	Detection Method	Functional Analysis Approach
  Phosphorylation	Phospho-proteomic MS	Kinase inhibitor studies, phosphomimetic mutations
  Glycosylation	Glycosidase sensitivity, lectin blotting	Glycosylation pathway mutants, site-directed mutagenesis
  Ubiquitination	Ubiquitin pull-down, K-ε-GG peptide enrichment	Proteasome inhibition, stability assays

These approaches can provide insights into how PTMs regulate Sup11p activity, localization, and stability, potentially revealing regulatory mechanisms that control its function in β-1,6-glucan synthesis and septum formation .

How conserved is SPCC320.05/Sup11p across fungal species, and what can this tell us about its function?

Analyzing the conservation of SPCC320.05/Sup11p across fungal species provides important evolutionary and functional insights:

• Phylogenetic distribution analysis:

  • Compare Sup11p sequences across yeast and filamentous fungi

  • Identify core conserved domains versus species-specific regions

  • Map conservation patterns to known functional domains

• Structure-function relationship:

  • Use comparative genomics to identify invariant residues likely critical for function

  • Correlate evolutionary conservation with structural features

  • Design experiments testing the functional importance of conserved motifs

• Functional complementation studies:

  • Express Sup11p homologs from other fungi in S. pombe sup11 mutants

  • Test whether homologs rescue septum formation and cell wall defects

  • Identify species-specific functional differences

• Evolutionary adaptation assessment:

  • Compare Sup11p sequence and function in fungi with different cell wall compositions

  • Identify potential co-evolution with other cell wall synthesis proteins

  • Investigate whether pathogenic fungi show adaptive changes in Sup11p structure

This comparative approach can reveal fundamental aspects of cell wall synthesis that are conserved across evolution while highlighting specialized adaptations, potentially informing both basic biology and antifungal development strategies.

What techniques are available for studying the SPCC320.05/Sup11p interactome across different growth conditions?

To investigate how the SPCC320.05/Sup11p interactome changes across different growth conditions, consider these advanced interactomics approaches:

• Quantitative interaction proteomics:

  • SILAC-based immunoprecipitation to quantify interaction changes between conditions

  • Proximity labeling methods (BioID/TurboID) under different growth conditions

  • Crosslinking mass spectrometry to capture transient interactions

• Live-cell interaction monitoring:

  • FRET biosensors to measure dynamic protein interactions

  • Split fluorescent protein complementation assays under varying conditions

  • Single-molecule tracking to analyze interaction kinetics

• Functional genomics integration:

  • Correlation of genetic interaction profiles across conditions

  • Conditional synthetic genetic arrays to identify context-dependent genetic interactions

  • Integration of transcriptomic and interactomic data to build condition-specific networks

• Visualization techniques:

  Condition	Recommended Approach	Expected Outcome
  Nutrient limitation	Co-immunoprecipitation with metabolic labeling	Identification of stress-specific interactions
  Cell cycle phases	Synchronized cultures with time-course sampling	Cell cycle-dependent interaction dynamics
  Cell wall stress	Chemical or genetic perturbation of cell wall	Stress-response interaction network

These methodologies can reveal how Sup11p interactions change during normal growth, stress responses, and developmental transitions, providing insights into the regulation of cell wall synthesis under different physiological states .

How can CRISPR/Cas9 technologies be applied to study SPCC320.05/Sup11p function?

CRISPR/Cas9 technologies offer powerful approaches for studying SPCC320.05/Sup11p function in fission yeast:

• Genome editing applications:

  • Generate precise point mutations to test functional hypotheses

  • Create conditional alleles using degron tags or inducible promoters

  • Introduce fluorescent tags at the endogenous locus for live-cell imaging

• Transcriptional modulation:

  • Use CRISPRi (dCas9) to achieve tunable repression of sup11 expression

  • Apply CRISPRa for controlled overexpression to study dosage effects

  • Create synthetic regulatory circuits to study dynamic expression requirements

• High-throughput functional genomics:

  • Perform CRISPR screens to identify genetic interactions with sup11

  • Use barcode-based pooled screens to assess phenotypes across conditions

  • Combine with single-cell RNA-seq to measure transcriptional consequences

• Advanced imaging applications:

  • CRISPR-based live-cell tagging for dynamic localization studies

  • Multicolor CRISPR labeling to visualize Sup11p with interaction partners

  • Optogenetic control of Sup11p activity or localization

These CRISPR-based approaches overcome limitations of traditional genetic methods by offering precise control, scalability, and compatibility with various downstream analyses .

What new technologies might improve our ability to visualize SPCC320.05/Sup11p at high resolution?

Emerging technologies offer unprecedented opportunities for high-resolution visualization of SPCC320.05/Sup11p:

• Super-resolution microscopy approaches:

  • STORM/PALM for nanoscale localization (10-20nm resolution)

  • SIM (Structured Illumination Microscopy) for improved resolution with live cells

  • Expansion microscopy to physically enlarge samples for conventional imaging

• Cryo-electron microscopy applications:

  • Cryo-electron tomography of vitrified cells to visualize Sup11p in native context

  • Correlative light and electron microscopy to combine molecular specificity with ultrastructural detail

  • Focused ion beam milling combined with cryo-ET for intact cell visualization

• Advanced fluorescent probes and sensors:

  • Split fluorescent proteins for visualizing protein-protein interactions

  • FRET/FLIM biosensors to detect conformational changes or PTMs

  • Photoconvertible tags to track protein movement and turnover

• Next-generation protein tagging:

  • Minimal tags with reduced functional interference

  • Self-labeling tags (SNAP, CLIP, Halo) for flexible experimental design

  • Multiplexed tagging for simultaneous visualization of multiple proteins

These technologies can reveal Sup11p's precise subcellular localization, molecular interactions, and dynamic behavior during cell wall synthesis and septum formation, potentially uncovering previously undetectable aspects of its function .

How might systems biology approaches integrate SPCC320.05/Sup11p research into broader cell wall synthesis networks?

Systems biology approaches can contextualize SPCC320.05/Sup11p within broader cell wall synthesis networks through these integrative methods:

• Multi-omics data integration:

  • Combine transcriptomics, proteomics, metabolomics, and genetic interaction data

  • Apply network inference algorithms to identify regulatory relationships

  • Use Bayesian networks to model causal relationships between components

• Mathematical modeling applications:

  • Develop kinetic models of β-1,6-glucan synthesis pathways

  • Create agent-based models of cell wall assembly

  • Use flux balance analysis to understand metabolic constraints on cell wall synthesis

• Pathway reconstruction and analysis:

  • Curate comprehensive maps of cell wall synthesis pathways

  • Identify feedback loops and regulatory nodes

  • Predict system-level responses to perturbations

• Translational systems approaches:

  Application	Method	Expected Outcome
  Drug target identification	Network vulnerability analysis	Identification of high-impact nodes
  Combination therapy design	Pathway redundancy mapping	Rational multi-target strategies
  Biomarker discovery	Network-based feature selection	Diagnostic/prognostic signatures

These systems approaches can transform our understanding of Sup11p from a single-protein focus to its role within the complex, interconnected processes of cell wall biogenesis, potentially revealing emergent properties and non-obvious regulatory relationships .